ICAR GUIDELINES Bundle (free trial)

Rhinology and Allergy Rhinosinusitis

ICAR IFAR GUIDELINES brought to you courtesy of Guideline Central. All of these titles are available for purchase on our website, GuidelineCentral.com. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/1512430

Contents of this Issue

Navigation

Page 22 of 27

23 Cost Benefit-Harm Assessment Policy Level Minimal Preponderance of benefit over harm Recommendation: Use of nasal saline irrigation In-office procedure with cost Preponderance of benefit over harm Recommendation: Postoperative debridement Moderate Preponderance of benefit over harm Strong Recommendation: Topical corticosteroids Moderate to high Balance of benefit and harm Option: Oral antibiotics Minimal Preponderance of harm over benefit Recommendation against: Topical decongestants Minimal Balance of benefit and harm Option: Systemic corticosteroids Moderate to high Balance of benefit and harm Recommendation against: Mitomycin C Costs associated with all packing materials. Absorbable materials are more costly than nonabsorbable packing Balance of risks and benefits Option: Although evidence does exist suggesting packing may reduce adhesion formation, it is limited and has not been compared to studies employing early and frequent debridement Variable depending on stents and medication Preponderance of benefit over harm Option: Corticosteroid- eluting stents can be considered in the postoperative ethmoidectomy cavity

Articles in this issue

view archives of ICAR GUIDELINES Bundle (free trial) - Rhinology and Allergy Rhinosinusitis